No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs62455030 |
chr7:64596820-64596821 |
Inactive region
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
2 |
rs62455031 |
chr7:64597122-64597123 |
Inactive region
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs62455032 |
chr7:64597405-64597406 |
Inactive region
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs535653050 |
chr7:64597464-64597465 |
Inactive region
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs1709521 |
chr7:64597546-64597547 |
Inactive region
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs2140593 |
chr7:64597624-64597625 |
Inactive region
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs534954477 |
chr7:64597683-64597684 |
Inactive region
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs558064133 |
chr7:64597800-64597801 |
Inactive region
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs577590077 |
chr7:64597802-64597803 |
Inactive region
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs543373654 |
chr7:64598194-64598195 |
Inactive region
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs1852022 |
chr7:64598235-64598236 |
Inactive region
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs550909593 |
chr7:64599770-64599771 |
Inactive region
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs545292279 |
chr7:64599882-64599883 |
Inactive region
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs373170395 |
chr7:64599890-64599891 |
Inactive region
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs189566333 |
chr7:64599895-64599896 |
Inactive region
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs2458804 |
chr7:64599912-64599913 |
Inactive region
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs536787131 |
chr7:64599935-64599936 |
Inactive region
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs547103420 |
chr7:64599956-64599957 |
Inactive region
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs565912731 |
chr7:64599969-64599970 |
Inactive region
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs534784786 |
chr7:64600024-64600025 |
Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs557785080 |
chr7:64600054-64600055 |
Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs565089355 |
chr7:64600058-64600059 |
Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs577828690 |
chr7:64600071-64600072 |
Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs369990956 |
chr7:64600095-64600096 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs372403278 |
chr7:64600099-64600100 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs536647120 |
chr7:64600171-64600172 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs552628513 |
chr7:64601104-64601105 |
Active TSS Bivalent/Poised TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs573121401 |
chr7:64601134-64601135 |
Active TSS Bivalent/Poised TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs545160892 |
chr7:64601145-64601146 |
Active TSS Bivalent/Poised TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs375114812 |
chr7:64601258-64601259 |
Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
31 |
rs369473769 |
chr7:64601260-64601261 |
Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
32 |
rs565446621 |
chr7:64601276-64601277 |
Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
33 |
rs531185471 |
chr7:64601340-64601341 |
Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs190224688 |
chr7:64601374-64601375 |
Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs146473372 |
chr7:64601414-64601415 |
Bivalent/Poised TSS Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs561371215 |
chr7:64601451-64601452 |
Bivalent/Poised TSS Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs181286047 |
chr7:64601522-64601523 |
Bivalent/Poised TSS Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs72504867 |
chr7:64601548-64601549 |
Bivalent/Poised TSS Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs186335692 |
chr7:64601564-64601565 |
Bivalent/Poised TSS Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs75249977 |
chr7:64601570-64601571 |
Bivalent/Poised TSS Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
41 |
rs143357318 |
chr7:64601579-64601580 |
Bivalent/Poised TSS Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs200287937 |
chr7:64601585-64601586 |
Bivalent/Poised TSS Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
43 |
rs532689861 |
chr7:64601598-64601599 |
Bivalent/Poised TSS Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs376553931 |
chr7:64601601-64601602 |
Bivalent/Poised TSS Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs370067068 |
chr7:64601602-64601603 |
Bivalent/Poised TSS Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs528305087 |
chr7:64601604-64601605 |
Bivalent/Poised TSS Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
47 |
rs140931305 |
chr7:64601606-64601607 |
Bivalent/Poised TSS Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs374380452 |
chr7:64601652-64601653 |
Bivalent/Poised TSS Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs2690473 |
chr7:64601679-64601680 |
Bivalent/Poised TSS Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs370812304 |
chr7:64601730-64601731 |
Bivalent/Poised TSS Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|